Lrrk2 mutations in south america: a study of Chilean Parkinson's disease

被引:20
|
作者
Perez-Pastene, Carolina
Cobb, Stephanie A.
Diaz-Grez, Fernando
Hulihan, Mary A.
Miranda, Marcelo
Venegas, Pablo
Godoy, Osvaldo Trujillo
Kachergus, Jennifer M.
Ross, Owen A.
Layson, Luis
Farrer, Matthew J.
Segura-Aguilar, Juan
机构
[1] Univ Chile, Fac Med, ICBM, Programme Mol & Clin Pharmacol, Santiago 7, Chile
[2] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
LRRK2; Parkinson's disease; mutation; Amerindian;
D O I
10.1016/j.neulet.2007.06.021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pathogenic substitutions in the leucine-rich repeat kinase 2 protein (Lrrk2), R1441G and G2019S, area prevalent cause of autosomal dominant and sporadic Parkinson's disease in the Northern Spanish population. In this study we examined the frequency of these two substitutions in 166 Parkinson's disease patients and 153 controls from Chile, a population with Spanish/European-Amerindian admixture. Lrrk2 R1441G was not observed, however Lrrk2 G2019S was detected in one familial and four sporadic Parkinson's disease patients. These findings suggest Lrrk2 G2019S may play an important role in Parkinson's disease on the South American Continent and further studies are now warranted. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:193 / 197
页数:5
相关论文
共 50 条
  • [21] Screening for LRRK2 mutations in patients with Parkinson's disease in Russia:: identification of a novel LRRK2 variant
    Pchelina, S. N.
    Yakimovskii, A. F.
    Emelyanov, A. K.
    Ivanova, O. N.
    Schwarzman, A. L.
    Singleton, A. B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (07) : 692 - 696
  • [22] Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease
    Ito, Genta
    Utsunomiya-Tate, Naoko
    BIOMOLECULES, 2023, 13 (05)
  • [23] An overview of the worldwide distribution of LRRK2 mutations in Parkinson's disease
    El Otmani, Hicham
    Daghi, Mohamed
    Tahiri Jouti, Nadia
    Lesage, Suzanne
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2023, 13 (06) : 335 - 350
  • [24] MIBG scintigraphy in Parkinson's disease with and without LRRK2 mutations
    Masso, J. F. Marti
    Martinez, J. Ruiz
    Bolano, M. J.
    Gorostidi, A.
    Marras, C.
    de Munain, A. J. Lopez
    MOVEMENT DISORDERS, 2008, 23 (01) : S254 - S255
  • [26] Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition
    Doggett, Elizabeth A.
    Zhao, Jing
    Mork, Christina N.
    Hu, Dongmei
    Nichols, R. Jeremy
    JOURNAL OF NEUROCHEMISTRY, 2012, 120 (01) : 37 - 45
  • [28] LRRK2 kinase in Parkinson's disease
    Alessi, Dario R.
    Sammler, Esther
    SCIENCE, 2018, 360 (6384) : 36 - 37
  • [29] Function of LRRK2 in Parkinson's Disease
    Zhu Fei-Zhou
    Xia Kun
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2010, 37 (10) : 1059 - 1066
  • [30] LRRK2 pathobiology in Parkinson's disease
    Martin, Ian
    Kim, Jungwoo Wren
    Dawson, Valina L.
    Dawson, Ted M.
    JOURNAL OF NEUROCHEMISTRY, 2014, 131 (05) : 554 - 565